These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28466400)

  • 1. The relationship of 19 functional polymorphisms in iodothyronine deiodinase and psychological well-being in hypothyroid patients.
    Young Cho Y; Jeong Kim H; Won Jang H; Hyuk Kim T; Ki CS; Wook Kim S; Hoon Chung J
    Endocrine; 2017 Jul; 57(1):115-124. PubMed ID: 28466400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scope and limitations of iodothyronine deiodinases in hypothyroidism.
    Gereben B; McAninch EA; Ribeiro MO; Bianco AC
    Nat Rev Endocrinol; 2015 Nov; 11(11):642-652. PubMed ID: 26416219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients.
    Panicker V; Saravanan P; Vaidya B; Evans J; Hattersley AT; Frayling TM; Dayan CM
    J Clin Endocrinol Metab; 2009 May; 94(5):1623-9. PubMed ID: 19190113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of type 2 iodothyronine deiodinase polymorphism.
    Maino F; Cantara S; Forleo R; Pilli T; Castagna MG
    Expert Rev Endocrinol Metab; 2018 Sep; 13(5):273-277. PubMed ID: 30257587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Polymorphisms of the Type 1 and Type 2 Iodothyronine Deiodinase Genes in Autoimmune Thyroid Diseases.
    Inoue N; Watanabe M; Katsumata Y; Ishido N; Hidaka Y; Iwatani Y
    Immunol Invest; 2018 Jul; 47(5):534-542. PubMed ID: 29648895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological relevance of deiodinase polymorphism.
    Bianco AC; Kim BS
    Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):341-346. PubMed ID: 30063552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodothyronine deiodinases and reduced sensitivity to thyroid hormones.
    Paragliola RM; Corsello A; Concolino P; Ianni F; Papi G; Pontecorvi A; Corsello SM
    Front Biosci (Landmark Ed); 2020 Jan; 25(2):201-228. PubMed ID: 31585886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of type II deiodinase polymorphisms in clinical management of hypothyroid patients treated with levothyroxine.
    Al-azzam SI; Alkhateeb AM; Al-Azzeh O; Alzoubi KH; Khabour OF
    Exp Clin Endocrinol Diabetes; 2013 May; 121(5):300-5. PubMed ID: 23329579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between DIO2 Thr92Ala polymorphism and hypertension in patients with hypothyroidism: Korean Genome and Epidemiology Study.
    Kang YM; Koo BS; Yi HS; Kim JT; Park B; Lee JH; Shong M; Kang YE
    Korean J Intern Med; 2023 Mar; 38(2):226-237. PubMed ID: 36646987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No Effect of the Thr92Ala Polymorphism of Deiodinase-2 on Thyroid Hormone Parameters, Health-Related Quality of Life, and Cognitive Functioning in a Large Population-Based Cohort Study.
    Wouters HJ; van Loon HC; van der Klauw MM; Elderson MF; Slagter SN; Kobold AM; Kema IP; Links TP; van Vliet-Ostaptchouk JV; Wolffenbuttel BH
    Thyroid; 2017 Feb; 27(2):147-155. PubMed ID: 27786042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Northern analysis of type II iodothyronine deiodinase mRNA in rat Harderian gland.
    Araki O; Murakami M; Kamiya Y; Hosoi Y; Ogiwara T; Mizuma H; Iriuchijima T; Mori M
    Life Sci; 1998; 63(21):1843-8. PubMed ID: 9825762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics in endocrinology: genetic variation in deiodinases: a systematic review of potential clinical effects in humans.
    Verloop H; Dekkers OM; Peeters RP; Schoones JW; Smit JW
    Eur J Endocrinol; 2014 Sep; 171(3):R123-35. PubMed ID: 24878678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ala92 type 2 deiodinase allele increases risk for the development of hypertension.
    Gumieniak O; Perlstein TS; Williams JS; Hopkins PN; Brown NJ; Raby BA; Williams GH
    Hypertension; 2007 Mar; 49(3):461-6. PubMed ID: 17224473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodothyronine-5'-deiodinase activity in progenies of hypothyroid rats.
    Porterfield SP; Hendrich CE
    Horm Metab Res; 1987 Dec; 19(12):609-12. PubMed ID: 3440566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients.
    Castagna MG; Dentice M; Cantara S; Ambrosio R; Maino F; Porcelli T; Marzocchi C; Garbi C; Pacini F; Salvatore D
    J Clin Endocrinol Metab; 2017 May; 102(5):1623-1630. PubMed ID: 28324063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selpercatinib-Induced Hypothyroidism Through Off-Target Inhibition of Type 2 Iodothyronine Deiodinase.
    Boucai L; Salas-Lucia F; Krishnamoorthy GP; Sherman E; Rudin CM; Drilon A; Bianco AC; Fagin JA
    JCO Precis Oncol; 2022 Jun; 6():e2100496. PubMed ID: 35704797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of UDP-glucuronyltransferase, beta-glucuronidase and deiodinase types I and II in hyper- and hypothyroid rats.
    van der Heide SM; Joosten BJ; Everts ME; Klaren PH
    J Endocrinol; 2004 Jun; 181(3):393-400. PubMed ID: 15171687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3'-triiodothyronine therapy.
    Appelhof BC; Peeters RP; Wiersinga WM; Visser TJ; Wekking EM; Huyser J; Schene AH; Tijssen JG; Hoogendijk WJ; Fliers E
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6296-9. PubMed ID: 16144953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma.
    Hoftijzer HC; Heemstra KA; Visser TJ; le Cessie S; Peeters RP; Corssmit EP; Smit JW
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1527-33. PubMed ID: 21715540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients.
    Arici M; Oztas E; Yanar F; Aksakal N; Ozcinar B; Ozhan G
    Endocr J; 2018 Mar; 65(3):317-323. PubMed ID: 29321381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.